{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:04:43Z","timestamp":1791194683810,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.atherosclerosis.2004.07.035","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T18:24:21Z","timestamp":1095791061000},"page":"165-172","source":"Crossref","is-referenced-by-count":45,"title":["Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals"],"prefix":"10.1016","volume":"178","author":[{"given":"Andr\u00e9","family":"Carpentier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine D.","family":"Uffelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Salit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary F.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/317491","article-title":"Disorders of glucose metabolism in patients infected with human immunodeficiency virus","volume":"31","author":"Dube","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2337\/diacare.22.9.1401","article-title":"Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes\u2014a prospective study","volume":"22","author":"Samaras","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib3","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/clinchem\/41.3.455","article-title":"Catecholamine interference with enzymatic determination of nonesterified fatty acids in two commercially available test kits","volume":"41","author":"Carr","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib5","first-page":"E549","article-title":"Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism","volume":"280","author":"Hruz","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib6","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0022-2275(20)38435-2","article-title":"Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis in vivo","volume":"29","author":"Grunfeld","year":"1988","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042560-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia","volume":"350","author":"Dube","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib10","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib11","doi-asserted-by":"crossref","first-page":"49U","DOI":"10.1016\/S0002-9149(98)00953-9","article-title":"Triglycerides as a risk factor for coronary artery disease","volume":"82","author":"Sprecher","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/317429","article-title":"Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the adult AIDS clinical trial group cardiovascular disease focus group","volume":"31","author":"Dube","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00041433-199706000-00004","article-title":"Fatty acid regulation of very low density lipoprotein production","volume":"8","author":"Lewis","year":"1997","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI10762","article-title":"Insulin resistance and cardiovascular disease","volume":"106","author":"Ginsberg","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/er.23.2.201","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocrine Rev"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2337\/diabetes.50.6.1402","article-title":"Effect of portal vs. systemic insulin delivery in pancreas transplantation on insulin action and VLDL metabolism","volume":"50","author":"Carpentier","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib17","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0022-2275(20)32434-2","article-title":"Stable isotope method using a [2H5]glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans","volume":"40","author":"Lemieux","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib18","first-page":"E1055","article-title":"Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation","volume":"276","author":"Carpentier","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib19","first-page":"73","article-title":"Stable isotopes in lipoprotein research: kinetic studies of very low density lipoprotein apolipoprotein B-100 metabolism in human subjects","volume":"3","author":"Cummings","year":"1996","journal-title":"Endocrinol Metabol"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00042560-200103010-00004","article-title":"Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy","volume":"26","author":"Schmitz","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib21","first-page":"E490","article-title":"Alterations in lipid kinetics in men with HIV-dyslipidemia","volume":"285","author":"Reeds","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm1201-1327","article-title":"HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia","volume":"7","author":"Liang","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib24","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1074\/jbc.M104557200","article-title":"Hiv protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus","volume":"276","author":"Riddle","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9343(91)80154-E","article-title":"Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"90","author":"Grunfeld","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib26","first-page":"74","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.ijo.0802037","article-title":"Fat-free mass index and fat mass index percentiles in Caucasians aged 18\u201398 y","volume":"26","author":"Schutz","year":"2002","journal-title":"Int J Obes Relat Metabol Disord"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib28","first-page":"E978","article-title":"Regional acetate kinetics and oxidation in human volunteers","volume":"274","author":"Mittendorfer","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib29","first-page":"51","article-title":"Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy","author":"Hadigan","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?","volume":"189","author":"Fontas","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00002030-200403260-00017","article-title":"Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients","volume":"18","author":"Negredo","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00002030-199905070-00009","article-title":"Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine","volume":"13","author":"Martinez","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib33","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/317426","article-title":"Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy","volume":"31","author":"Martinez","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.atherosclerosis.2004.07.035_bib34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2014association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004004228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004004228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T21:02:35Z","timestamp":1624654955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915004004228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0021915004004228"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.07.035","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}